Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in 2020

European Healthtech startup funding raised during 2020.

In 2020, 490 European Healthtech companies closed 518 funding rounds and raised €6.1B in equity funding (excluding debt and grants). Debt rounds added €65M. UK led by capital raised, and Novo Holdings was the most active investor. Data as of 18 Nov 2026.

Equity funding
€6.1B
excl. debt & grants · +€65M debt
Funding rounds
518
Companies
490
Top country
UK

Healthtech: last three years

change vs the year before
YearEquityChangeRoundsChangeDebt
2018€2.9B-17.5%318-17.2%—
2019€4.1B+42.0%399+25.5%—
2020€6.1B+48.1%518+29.8%€65M
Break down 2020 by period
Rank among sectors
#4
9.5% of sector funding
Debt financing
€65M
1.1% of total
Top-10 round share
19.5%
of disclosed capital
Rounds ≥ €100M
5

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, 2020 — interactive chart.
Data table
FundingRounds
Jan€347M54
Feb€365M37
Mar€164M18
Apr€533M39
May€412M35
Jun€612M20
Jul€858M60
Aug€365M40
Sep€865M64
Oct€776M60
Nov€545M51
Dec€322M40

Top countries

by € raised
Healthtech — top countries by capital, 2020 — interactive chart.
Data table
Healthtech — top countries by capital, 2020
UK€1.4B
Israel€1.0B
Switzerland€704M
Germany€701M
France€679M
Sweden€409M
Netherlands€297M
Spain€253M

Stage mix

by € raised
Healthtech — stage mix, 2020 — interactive chart.
Data table
Healthtech — stage mix, 2020
Other€1.9B
Series C€1.1B
Series B€1.0B
Series A€908M
Series D+€472M
Early VC€387M
Seed€257M
Growth/Late€93M
Debt€65M
Grant€27M
Crowdfunding€8.6M
Pre-Seed€7.7M

Exits & M&A

37 Acquisition · 2 IPO · 1 Buyout

43 exits · €2.5B disclosed.

MYR GmbHAcquisitionOct 2020€1.1B
Polyplus-TransfectionAcquisitionFeb 2020€460M
GalectoAcquisitionJan 2020€398M
MaSTherCellAcquisitionFeb 2020€285M
Nanox ImagingIPOAug 2020€140M
FiagonAcquisitionSep 2020€60M

Largest equity rounds

by disclosed amount, 2020
CompanyStageDateAmount
CureVacEarly VCJun 2020€300M
KrySeries CJul 2020€140M
Oxford Nanopore TechnologiesOtherApr 2020€124M
Freeline TherapeuticsSeries CJul 2020€107M
Atai Life SciencesSeries CNov 2020€105M
Sophia GeneticsSeries D+Oct 2020€94M
VectivbioOtherOct 2020€94M
Neogene TherapeuticsOtherSep 2020€93M
Compass PathwaysSeries BApr 2020€74M
Freeline TherapeuticsSeries CJul 2020€71M

Largest debt rounds

debt financing, 2020; not in the equity total
CompanyStageDateAmount
Cycle PharmaceuticalsDebtSep 2020€21M
KerecisDebtAug 2020€18M
Scope FluidicsDebtSep 2020€10M
Rheon MedicalDebtDec 2020€5.2M
DoctorlyDebtNov 2020€4.7M

Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology